Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Momenta Pharmaceuticals

Request full access

Biotechnology company specializing in the characterization and process engineering of complex molecules

Cambridge, United StatesFounded 2001Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2004

Momenta Pharmaceuticals in the Cambridge ecosystem

Live from Dealroom

The Momenta Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later5 investors entered at this stage

  • MVM Life Science Partners
  • Mithra Ventures
  • Cardinal Partners
  • Atlas Venture
  • Massachusetts Institute of Technology
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 6 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$70M

58 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Momenta Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.